Can knowledge about brown bears contribute to development of a vaccine against atherosclerosis in humans?
Online consultations are the solution—but to which problems?
16 June 2021FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments
16 June 2021Can knowledge about brown bears contribute to development of a vaccine against atherosclerosis in humans?
High blood lipids and inactivity are two risk factors for atherosclerosis in humans. When the European brown bear (Ursus arctos) hibernates during winter, it is inactive for 5-6 months and also develops high blood lipids, but still show no signs of atherosclerosis.
